Detalles de la búsqueda
1.
Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis.
Int J Mol Sci
; 25(3)2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38338977
2.
Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies.
Int J Mol Sci
; 23(4)2022 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216197
3.
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.
Arch Virol
; 166(11): 2955-2974, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390393
4.
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication.
Int J Mol Sci
; 22(1)2020 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33396807
5.
Genetic diversity in the env V1-V2 region of proviral quasispecies from long-term controller MHC-typed cynomolgus macaques infected with SHIVSF162P4cy.
J Gen Virol
; 99(12): 1717-1728, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30311877
6.
The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
Int J Mol Sci
; 19(5)2018 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747434
7.
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
Retrovirology
; 13(1): 34, 2016 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27277839
8.
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
BMC Infect Dis
; 16(1): 442, 2016 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27549342
9.
Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
BMC Infect Dis
; 16: 344, 2016 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27450538
10.
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
Retrovirology
; 12: 33, 2015 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924841
11.
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.
Retrovirology
; 11: 49, 2014 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24961156
12.
The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells.
Angiogenesis
; 17(4): 831-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24719186
13.
Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16Ink4a.
Int J Gynecol Cancer
; 23(9): 1663-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24172101
14.
Antitumour effects of antiretroviral therapy.
Nat Rev Cancer
; 4(11): 861-75, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15516959
15.
HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine.
Expert Rev Vaccines
; 21(9): 1243-1253, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695268
16.
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
Int J Cancer
; 128(1): 82-93, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20617515
17.
Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P.
J Virol
; 84(17): 8953-8, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20554774
18.
Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein.
AIDS Care
; 23(8): 939-46, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21390884
19.
Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.
J Immunol
; 182(6): 3718-27, 2009 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19265150
20.
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
J Immunol
; 182(5): 2888-97, 2009 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19234184